Skip to main content

Autolus Therapeutics plc

AUTL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001730463

In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Autolus Therapeutics plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
66
0 vs. Q2 2022
Shares held
49.4M
−1.46M (−2.9%) vs. Q2 2022
Total value
$105.7M
−$38.2M (−26.5%) vs. Q2 2022
New holders
7
14 more added
Sold out
7
21 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AUTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 66 institutions
Q1 2021: 63 institutionsQ2 2021: 69 institutionsQ3 2021: 59 institutionsQ4 2021: 73 institutionsQ1 2022: 66 institutionsQ2 2022: 67 institutionsQ3 2022: 66 institutionsQ4 2022: 71 institutionsQ1 2023: 65 institutionsQ2 2023: 69 institutionsQ3 2023: 71 institutionsQ4 2023: 99 institutionsQ1 2024: 120 institutionsQ2 2024: 111 institutionsQ3 2024: 101 institutionsQ4 2024: 110 institutionsQ1 2025: 95 institutionsQ2 2025: 94 institutionsQ3 2025: 96 institutionsQ4 2025: 89 institutionsQ1 2026: 84 institutionsQ2 2026: 83 institutions
Value heldQ3 2022: $105.7M
Q1 2021: $129.4MQ2 2021: $169.6MQ3 2021: $164.2MQ4 2021: $272.3MQ1 2022: $228.6MQ2 2022: $143.9MQ3 2022: $105.7MQ4 2022: $204.2MQ1 2023: $195.1MQ2 2023: $260.4MQ3 2023: $258.1MQ4 2023: $746.6MQ1 2024: $1.12BQ2 2024: $620.0MQ3 2024: $648.5MQ4 2024: $395.4MQ1 2025: $261.0MQ2 2025: $378.6MQ3 2025: $235.7MQ4 2025: $277.1MQ1 2026: $184.4MQ2 2026: $212.0M
Institutions holding AUTL and their total value by quarter
QuarterHoldersValue
Q2 202683$212.0M
Q1 202684$184.4M
Q4 202589$277.1M
Q3 202596$235.7M
Q2 202594$378.6M
Q1 202595$261.0M
Q4 2024110$395.4M
Q3 2024101$648.5M
Q2 2024111$620.0M
Q1 2024120$1.12B
Q4 202399$746.6M
Q3 202371$258.1M
Q2 202369$260.4M
Q1 202365$195.1M
Q4 202271$204.2M
Q3 202266$105.7M
Q2 202267$143.9M
Q1 202266$228.6M
Q4 202173$272.3M
Q3 202159$164.2M
Q2 202169$169.6M
Q1 202163$129.4M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Autolus Therapeutics plc; share changes are against Q2 2022.

Institutions holding AUTL in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Blackstone Group Inc.17,985,611$38.5M0.14%00.0%Unchanged
Syncona Portfolio Ltd7,346,829$15.7M27.32%00.0%Unchanged
Nantahala Capital Management, LLC5,215,788$11.2M1.09%+72,933+1.4%Added
Frazier Life Sciences Management, L.P.3,746,857$8.02M0.62%00.0%Unchanged
Polygon Management Ltd.3,039,381$6.50M0.78%+19,968+0.7%Added
Schroder Investment Management Group1,672,732$3.58M0.01%00.0%Unchanged
Pendal Group Limited1,370,757$2.93M0.03%+5,328+0.4%Added
Citadel Advisors LLC1,142,605$2.44M0.00%−1,011,052−46.9%Reduced
Alphabet Inc.698,262$1.49M0.08%00.0%Unchanged
Capital World Investors625,000$1.34M0.00%00.0%Unchanged
UBS Oconnor LLC584,406$1.25M0.01%+1600.0%Added
LGT Capital Partners Ltd.550,000$1.18M0.04%00.0%Unchanged
DAFNA Capital Management LLC496,150$1.06M0.29%00.0%Unchanged
BlackRock Inc.446,855$956.0K0.00%−20,991−4.5%Reduced
JPMorgan Chase & Co442,550$947.0K0.00%−183,969−29.4%Reduced
Woodline Partners LP428,255$916.0K0.01%−297,859−41.0%Reduced
Cormorant Asset Management, LP392,167$839.0K0.06%00.0%Unchanged
Wells Fargo & Company389,839$834.0K0.00%+25,884+7.1%Added
FMR LLC381,318$816.0K0.00%+1,133+0.3%Added
MAI Capital Management359,110$768.0K0.01%−6,297−1.7%Reduced
Ikarian Capital, LLC260,087$556.0K0.28%−62,130−19.3%Reduced
ExodusPoint Capital Management, LP204,316$437.0K0.01%+55,281+37.1%Added
Harbor Capital Advisors, Inc.148,454$318.0K0.30%−16,452−10.0%Reduced
Cetera Investment Advisers135,400$290.0K0.01%+8,400+6.6%Added
Geode Capital Management, LLC133,438$285.0K0.00%00.0%Unchanged
Erste Asset Management GmbH120,000$267.6K0.01%00.0%Unchanged
Privium Fund Management B.V.113,528$253.0K0.10%+15,000+15.2%Added
MYDA Advisors LLC100,000$214.0K0.12%00.0%Unchanged
Kettle Hill Capital Management, LLC89,792$192.0K0.05%+89,792New
Caxton Associates LP84,156$180.0K0.03%−5,200−5.8%Reduced
Millennium Management LLC79,010$169.0K0.00%−158,649−66.8%Reduced
Legal & General Group Plc67,517$146.0K0.00%00.0%Unchanged
State Street Corp53,317$114.0K0.00%−610−1.1%Reduced
Alps Advisors Inc49,657$106.0K0.00%−4,274−7.9%Reduced
Morgan Stanley43,950$94.0K0.00%−24,433−35.7%Reduced
Wealth Effects LLC43,600$93.0K0.06%+5,500+14.4%Added
UBS Group AG41,775$89.0K0.00%−298−0.7%Reduced
Boothbay Fund Management, LLC27,215$58.0K0.00%−4,963−15.4%Reduced
Renaissance Technologies LLC25,200$54.0K0.00%+12,400+96.9%Added
LPL Financial LLC23,200$50.0K0.00%+23,200New
Gsa Capital Partners LLP22,885$49.0K0.01%+22,885New
Northeast Financial Consultants Inc19,672$42.0K0.00%00.0%Unchanged
Jane Street Group, LLC19,289$41.0K0.00%+4,572+31.1%Added
Goldman Sachs Group Inc18,851$40.0K0.00%−2,188−10.4%Reduced
Bayshore Asset Management, LLC17,500$37.0K0.03%00.0%Unchanged
American Portfolios Advisors16,925$36.2K0.00%00.0%Unchanged
Cannell Capital LLC16,835$36.0K0.01%+12,834+320.8%Added
Weiss Multi-Strategy Advisers LLC13,324$29.0K0.00%−429−3.1%Reduced
Blair William & Co13,341$29.0K0.00%00.0%Unchanged
Cubist Systematic Strategies, LLC12,618$27.0K0.00%−8,869−41.3%Reduced
Susquehanna International Group, LLP12,140$26.0K0.00%−4,477−26.9%Reduced
US Bancorp7,652$16.0K0.00%+7,652New
Tower Research Capital LLC (TRC)6,507$14.0K0.00%+3,053+88.4%Added
Group One Trading, L.P.5,900$13.0K0.00%00.0%Unchanged
Huntington National Bank1,501$3.00K0.00%00.0%Unchanged
Citigroup Inc758$2.00K0.00%−199−20.8%Reduced
Ulland Investment Advisors, LLC1,000$2.00K0.00%00.0%Unchanged
Quadrant Capital Group LLC921$2.00K0.00%+921New
Bank of America Corp517$1.00K0.00%−109−17.4%Reduced
Advisor Group Holdings, Inc.500$1.00K0.00%00.0%Unchanged
Carmichael Hill & Associates, Inc.508$1.00K0.00%00.0%Unchanged
China Universal Asset Management Co., Ltd.542$1.00K0.00%+542New
BNP Paribas Arbitrage, SA66$1410.00%−944−93.5%Reduced
Royal Bank of Canada44$00.00%00.0%Unchanged
Daiwa Securities Group Inc.74$00.00%00.0%Unchanged
State of Wyoming51$00.00%+51New
Acadian Asset Management LLC0$00.00%−34,888−100.0%Sold out
Total Clarity Wealth Management, Inc.0$00.00%−1,200−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−500−100.0%Sold out
Captrust Financial Advisors0$00.00%−500−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−177−100.0%Sold out
Cutler Group LP0$00.00%−100−100.0%Sold out
Curi Capital0$00.00%−137−100.0%Sold out
Exane Derivatives––––Not filed